Formosa Pharmaceuticals in Taiwan has signed an exclusive licensing agreement with Medvisis Switzerland to commercialise ...

A clinical diagnosis was made of psoriasis and he was prescribed clobetasol propionate ointment with salicylic acid 6% in petrolatum that should be applied in the evening to his elbows and knees ...

The company’s current commercial portfolio includes clobetasol propionate ophthalmic suspension ... for additional multi-billion-dollar indications where the Optejet may be advantageous ...

The company’s current commercial portfolio includes clobetasol propionate ophthalmic suspension, 0.05%, for post-surgical pain and inflammation, and Mydcombi ® for mydriasis. Eyenovia has also secured ...

The drug is available as an injection given under the skin or as an IV infusion. Its dosing frequency depends on the condition being treated. Tremfya is used to treat the following in adults in ...

According to the company, there are no FDA-approved pharmacological therapies for age-related cataracts. Its C-KAD eye drop, improves vision in patients with early-to-moderate cataracts, by ...

The drug information contained herein is subject to change and is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects.